{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:27:10Z","timestamp":1773289630699,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007560.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000}}],"reference-count":54,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007560.pub3","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T12:14:35Z","timestamp":1439295275000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Methotrexate for maintenance of remission in ulcerative colitis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Yongjun","family":"Wang","sequence":"first","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[{"name":"University of Alberta; Department of Pediatrics; 4-496B Edmonton Clinic Health Academy (ECHA) 11405 - 87 Avenue Edmonton AB Canada T6G 1C9"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Griffiths","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children; Division of Gastroenterology, Hepatology & Nutrition; 555 University Ave. Toronto ON Canada M5G 1X8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"El-Matary","sequence":"additional","affiliation":[{"name":"Children's Hospital, Health Sciences Centre; Section of Pediatric Gastroenterology; AE-408 840 Sherbrook St. Winnipeg MB Canada R3A 1S1"},{"name":"University of Manitoba; Department of Pediatrics, Faculty of Medicine; Winnipeg MB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD007560.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mate-Jimenez","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007560.pub3-BIB0002|cit2","first-page":"A75","article-title":"Low-dose weekly methotrexate therapy in remission maintenance in ulcerative colitis","volume":"39","author":"Onuk","year":"1996","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/gast.1996.v110.pm8613046","article-title":"Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial","volume":"110","author":"Oren","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S517","DOI":"10.14309\/00000434-201310001-01716","article-title":"Effects of immunomodulators on the pharmacokinetics and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from phase 2\/3 pursuit-SC induction and maintenance studies","volume":"108","author":"Adedokun","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/01.mpg.0000348230.14277.d1","article-title":"Role of methotrexate in pediatric ulcerative colitis","volume":"48","author":"Aloi","year":"2009","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD007560.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2010.04433.x","article-title":"Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre","volume":"32","author":"Aloi","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/BF01296109","article-title":"Low-dose oral methotrexate in refractory inflammatory bowel disease","volume":"38","author":"Baron","year":"1993","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2005.02331.x","article-title":"Oral methotrexate in ulcerative colitis","volume":"21","author":"Cummings","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub3-BIB0009|cit9","first-page":"175","article-title":"Long-term parenteral therapy with methotrexate in refractory ulcerative colitis: preliminary results","volume":"7","author":"Dejica","year":"1998","journal-title":"Romanian Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD007560.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1365-2036.1999.00667.x","article-title":"A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis","volume":"13","author":"Egan","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD007560.pub3-BIB0011|cit11","first-page":"A227","article-title":"A randomized, single-blind, pharmacokinetic and dose response study of subcutaneous methotrexate, 15 and 25 mg\/week, for refractory ulcerative colitis and Crohn's disease","volume":"114","author":"Egan","year":"1998","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00054725-200011000-00005","article-title":"Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease","volume":"6","author":"Egan","year":"2000","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007560.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2036.2002.01227.x","article-title":"The efficacy of methotrexate for maintaining remission in inflammatory bowel disease","volume":"16","author":"Fraser","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD007560.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"A525","DOI":"10.1016\/S0016-5085(03)82658-6","article-title":"Parenteral methotrexate is not effective treatment for refractory ulcerative colitis","volume":"125","author":"Fraser","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.14309\/00000434-201110002-01217","article-title":"Use of methotrexate in children and young adults affected by ulcerative colitis: a retrospective study","volume":"106","author":"Ghiselli","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD007560.pub3-BIB0016|cit16","first-page":"A661","article-title":"Subcutaneous methotrexate: a safe and effective therapy in IBD","volume":"130","author":"Gibson","year":"2006","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007560.pub3-BIB0018|cit17","first-page":"A662","article-title":"Efficacy and safety of methotrexate therapy in inflammatory bowel disease. The Madrid experience","volume":"136","author":"Gonz\u00e1lez-Lama","year":"2009","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD007560.pub3-BIB0017|cit18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/MEG.0b013e3283556db5","article-title":"Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience","volume":"24","author":"Gonz\u00e1lez-Lama","year":"2012","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007560.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1016\/S0016-5085(13)61584-X","article-title":"A comparison of efficacy, pharmacokinetics and immunogenicity in patients with ulcerative colitis receiving infliximab monotherapy versus combination therapy","volume":"144","author":"Hayes","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/jgh.12517","article-title":"Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono- versus combination therapy in ulcerative colitis","volume":"29","author":"Hayes","year":"2014 Jun","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.fpc.0000172242.19675.33","article-title":"The pharmacogenetics of methotrexate in inflammatory bowel disease","volume":"15","author":"Herrlinger","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"issue":"51","key":"10.1002\/14651858.CD007560.pub3-BIB0022|cit22","first-page":"2552","article-title":"Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease","volume":"138","author":"Houben","year":"1994","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S1873-9946(13)60673-X","article-title":"Early treatment with immunomodulators is associated with change in the natural history of inflammatory bowel disease - multicentre longitudinal cohort study - Sydney, Australia","volume":"7","author":"Kariyawasam","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0024|cit24","first-page":"S98","article-title":"Methotrexate use in inflammatory bowel disease: a referral centre's 30 years of experience","volume":"6","author":"Katsanos","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD007560.pub3-BIB0026|cit26","first-page":"A648","article-title":"Long-term use of methotrexate in inflammatory bowel disease","volume":"102","author":"Kozarek","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.crohns.2011.03.012","article-title":"Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy","volume":"5","author":"Ma\u00f1osa","year":"2011 Oct","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1440-1746.2007.05006.x","article-title":"A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration","volume":"23","author":"Nathan","year":"2008","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1365-2036.2002.01340.x","article-title":"Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission","volume":"16","author":"Paoluzi","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0030|cit30","first-page":"A92","article-title":"Rescue methotrexate therapy in chronic active ulcerative colitis patients intolerant of thiopurines","volume":"54","author":"Rook","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2036.2003.01480.x","article-title":"Methotrexate in ulcerative colitis","volume":"17","author":"Siveke","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD007560.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200409000-00018","article-title":"Experience with the use of low-dose methotrexate for inflammatory bowel disease","volume":"16","author":"Soon","year":"2004","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2036.2009.04073.x","article-title":"Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine \/mercaptopurine","volume":"30","author":"Wahed","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0034|cit34","first-page":"Conference: Can","article-title":"Methotrexate in the treatment of inflammatory bowel disease: An 8-year retrospective study on 91 patients treated in a Canadian pediatric IBD centre","volume":"23","author":"Willot","year":"2009","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"22","key":"10.1002\/14651858.CD007560.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/ibd.21653","article-title":"Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center","volume":"17","author":"Willot","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007560.pub3-BIB0036|cit36","first-page":"S690","article-title":"Infliximab monotherapy vs. combined infliximab-immunomodulator therapy in ulcerative colitis","volume":"138","author":"Zadvornova","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0037|cit37","unstructured":"NCT00498589 A controlled, randomized, double-blind, multicenter study, comparing methotrexate vs placebo in corticosteroid-dependent ulcerative colitis https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00498589"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0038|cit38","unstructured":"NCT01393405 Randomized, double blind, prospective trial investigating the efficacy of methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC) https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01393405"},{"issue":"6","key":"10.1002\/14651858.CD007560.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2036.2007.03334.x","article-title":"Review article: the management of steroid dependency in ulcerative colitis","volume":"26","author":"Bianchi Porro","year":"2007","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD007560.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006618.pub3","article-title":"Methotrexate for induction of remission in ulcerative colitis","author":"Chande","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD007560.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200303000-00003","article-title":"Methotrexate: first-line or second-line immunomodulator?","volume":"15","author":"Fraser","year":"2003","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"7650","key":"10.1002\/14651858.CD007560.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD007560.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.fpc.0000172242.19675.33","article-title":"The pharmacogenetics of methotrexate in inflammatory bowel disease","volume":"15","author":"Herrlinger","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"issue":"7414","key":"10.1002\/14651858.CD007560.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0047|cit47","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD007560.pub3-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003459.pub4","article-title":"Methotrexate for induction of remission in refractory Crohn's disease","author":"McDonald","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007560.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0049-0172(94)90027-2","article-title":"Low-dose methotrexate in rheumatic disease -- efficacy, side effects, and risk factors for side effects","volume":"23","author":"Schnabel","year":"1994","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1572-0241.2003.07305.x","article-title":"Low dose methotrexate in inflammatory bowel disease: current status and future directions","volume":"98","author":"Schroder","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD007560.pub3-BIB0051|cit51","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD007560.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/j.1572-0241.2000.03287.x","article-title":"Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease","volume":"95","author":"Te","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD007560.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/j.1572-0241.2007.01474.x","article-title":"Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn disease","volume":"102","author":"Turner","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD007560.pub3-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007560.pub2","article-title":"Methotrexate for maintenance of remission in ulcerative colitis","author":"El-Matary","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007560.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T01:47:25Z","timestamp":1662342445000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007560.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007560.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725713055.793514455","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}